Additionally, preliminary data suggest anti-inflammatory effects of DS and other insulin receptor sensitizers which were used in clinical[32,34,37] and pre-clinical studies[82]; this can per se, underlie an antidepressant effect taking into account emerging evidence for the role of inflammatory mechanisms in depression[83,84]. The gene discussed is INSR; the disease is depressive symptom measurement.